Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.515 USD | -0.09% | +5.44% | -14.34% |
20/05 | Foghorn Therapeutics Prices $110 Million Offering of Shares, Pre-Funded Warrants | MT |
06/05 | Foghorn Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.34% | 305M | |
+16.47% | 122B | |
+20.42% | 115B | |
+21.34% | 26.64B | |
-23.00% | 19.91B | |
-17.47% | 16.32B | |
-45.95% | 15.52B | |
-19.15% | 15.49B | |
+60.10% | 14.83B | |
+2.34% | 13.67B |
- Stock Market
- Equities
- FHTX Stock
- News Foghorn Therapeutics Inc.
- Foghorn® Therapeutics Appoints Carl P. Decicco, Ph.D. as Chief Scientific Officer